Pandemic, quarantine, vaccines, the growth of the IT sector, antitrust litigation of technology corporations, the explosive success of Tesla, and, of course, Brexit - these are our most significant events of the year.
The vaccine developed by Pfizer and BioNTech is officially the first FDA-approved vaccine against COVID 19. In this article, we will define the arguments and try to figure out whether it will be possible to make money on investments in these companies.
What does the appearance of the new strain mean?
At the beginning of November, it became know that American Airlines (NASDAQ: AAL) was carrying out an SPO. In this article, we will find out what it means and how it might influence the stock price.
Now those investors who missed the growth of stock prices in summer have to look for something to make money on. The time has come to pay attention to pharmaceutical companies again.
COVID-19. Unofficially, we have a vaccine. Officially, we might have it in May.
The S&P500 index is renewing its historical maximums. All seems to go well but analysts keep mentioning yet another wave of crisis that should have come a year ago; however, falling of the stock indices is postponed all the time. In the end, those traders who accumulated short positions are made to close them, pushing the price up.
Falling of Pfizer stocks in April 2019 was used by investors as a good chance to buy them. This time the stocks have fallen again, so let us try to figure out the reasons for this as well as the perspectives of long-term investing in them.
Today, we''ll focus more on technical analysis, using fundamentals only to confirm the tech analysis result or prove it wrong. In practice, tech analysis often predicts the events the retail investors are not aware of.